Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Irene Zamanillo et al.|European Journal Of Haematology|2020Cited by 96
Impact of COVID-19 in patients with multiple myeloma based on a global data networkJoaquín Martínez‐López, Gema Hernández, R. Alonso et al.|Blood Cancer Journal|2021Cited by 59
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple MyelomaAlba Rodríguez-García, María Linares, Andrés Arroyo et al.|Clinical Cancer Research|2023Cited by 59
Clinical Course and Risk Factors for Mortality from COVID-19 in Patients with Hematological MalignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|SSRN Electronic Journal|2020Cited by 1
Large Scale Analysis of Autologous Stem Cell Transplantation for Multiple Myeloma Patients Older Than 65 YearsAdolfo Jesús Sáez Marín, Joaquín Martínez‐López, Gema Hernández et al.|Blood|2023Cited by 1